CVE-2026-30312
CRITICAL OS command injection in DSAI-Cline command auto-approval.
Is CVE-2026-30312 being exploited?
Not confirmed. CVE-2026-30312 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 1.7% probability of exploitation in the next 30 days.
How severe is CVE-2026-30312?
CVE-2026-30312 is rated Critical with a CVSS score of 9.8. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-30312?
Not known from our data. No patch reference has been recorded for CVE-2026-30312, which is not the same as no patch existing — a fix may have shipped without a tagged reference, or after this record was written. The vendor advisory is the only authority on whether a fix exists, and mitigations may be available regardless.
What does CVE-2026-30312 affect?
CVE-2026-30312 affects DSAI-Cline Command Auto-Approval Module, DSAI-Cline Platform. Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-30312?
Patch when available; temporarily disable auto-approval.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Remote Code Execution via newline-injected payload bypassing the whitelist; PowerShell executes malicious command.
Immediate action required